MYTX-011: A pH-Dependent Anti-c-MET Antibody-Drug Conjugate Designed for Enhanced Payload Delivery to c-MET-Expressing Tumor Cells.
Gera N, Fitzgerald KM, Ramesh V, Patel P, Kanojia D, Colombo F, Kien L, Aoyama S, Xu L, Jean J, Deshpande AM, Comb WC, Chittenden T, Fiske BP.
Gera N, et al. Among authors: patel p.
Mol Cancer Ther. 2024 Jun 10:OF1-OF12. doi: 10.1158/1535-7163.MCT-23-0784. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 38853438